Dyne Therapeutics, Inc.
DYN
$25.70
-$0.26-1.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -519.41M | -451.71M | -446.21M | -423.80M | -412.89M |
| Total Depreciation and Amortization | 2.15M | 2.10M | 2.05M | 1.98M | 1.89M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.70M | 44.80M | 44.36M | 43.29M | 40.30M |
| Change in Net Operating Assets | -10.27M | -37.43M | -3.40M | 2.82M | 11.13M |
| Cash from Operations | -477.82M | -442.24M | -403.21M | -375.71M | -359.56M |
| Capital Expenditure | -21.40M | -19.95M | -20.71M | -21.30M | -2.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.77M | -12.65M | -8.04M | -24.44M | -24.81M |
| Cash from Investing | -44.17M | -32.60M | -28.75M | -45.74M | -27.18M |
| Total Debt Issued | 116.94M | 155.04M | 148.26M | 98.80M | 98.80M |
| Total Debt Repaid | -3.90M | -579.00K | -- | -- | -- |
| Issuance of Common Stock | 601.44M | 602.68M | 742.61M | 364.73M | 164.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.01M | -1.01M | -558.00K | -549.00K | -- |
| Cash from Financing | 713.47M | 756.13M | 890.31M | 462.98M | 263.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 191.48M | 281.29M | 458.35M | 41.53M | -123.08M |